Preview

Health and Ecology Issues

Advanced search

ALTERNATIVE APPROACH IN TREATMENT OF ACUTE URINARY RETENTION IN BENIGN PROSTATIC HYPERPLASIA

https://doi.org/10.51523/2708-6011.2017-14-1-11

Abstract

The purpose of this article is to consider options of treatment ofacute urinary retention (AUR) in patients with benign prostatic hyperplasia (BPH). We examined and treated 80 BPH patients with AUR and without it in their pastmedical history. The patients were divided into two homogeneous groups of 40 people: group I did not have AUR in their history andgroup II did. Group II consisted of two subgroups: a) having undergone conservative treatment; b) having undergone surgical treatment (cystostomy). Subgroup II-B also included those patients who refused to undergo the second stage of the surgery or had any contraindications tothe operation. However, even the presence ofcystostomic drainage does not exclude the option of drug therapy for restoration of the natural urinary outflow. Therefore, forehanded and reasonable BPH treatment makes it possible to minimize the risks of acute unirary retention for BPH patients.

About the Authors

N. I. Simchenko
Gomel State Medical University
Belarus


M. B. Lemtyugov
Gomel State Medical University
Belarus


O. O. Bykova
Mogilev Regional Hospital
Belarus


References

1. Аляев, Ю. Г. Лечение больных аденомой предстательной железы ингибитором 5-альфа-редуктазы I и II типа Аводартом (дутастерид) // Ю. Г. Аляев, А. З. Винаров, К. Л. Локшин // Урология. - 2006. - № 6. - С. 83-86.

2. Лопаткин, Н. А. Доброкачественная гиперплазия предстательной железы / под ред. Н. А. Лопаткина. - М., 2001. -236 с.

3. Andersson, K. E. Current concepts in the treatment of disorders of micturition. / K. E. Andersson // Drugs. - 2008. - № 35. -P. 77-94.

4. A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance / C. J. Kelleher [et al.] // Br J Obstet Gynaecol. - 1997. - Vol. 104. - P. 988-993.

5. The effect of finasteride in men with benign prostatic hyperplasia. The FinasterideStady Group / G. Gormley [et al.] // N. Engl. J. Med. - 1992. - Vol. 327, № 17. - P. 1185-1191.

6. Abrams, P. The significance of the symptoms associated with bladder outflow obstruction / P. Abrams, R. Feneley // UrolInt. - 2008. - P. 33.

7. Ткачук, В. Н. Медикаментозное лечение доброкачественной гиперплазии предстательной железы / В. Н. Ткачук. - М.: МДВ, 2009. - 128 с.

8. Efficacy and safety of a dual ingibitor of 5alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia / C. G. Roehrborn [et al.] // Urology. - 2002. - Vol. 60, № 3. - P. 434-444.

9. Efficacy and safety of a long-term treatment with the dual 5alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia / F. Debuyne [et al.] // Eur. Urol. - 2004. - P. 23-28.

10. Andersson, K. E. Adrenoreceptor stimulants and blockaders in obstetrics, gynecology and urology / K. E. Andersson // Receptor farmacology. Lakartidningen. - 1998. - Vol. 50. - P. 332-335.

11. Clinical uroselectivity: Evidence from patients treated with slow-release alfuzosin for symptomatic benign prostatic obstruction / J. M. Buzelin [et al.] // Br J Urol. - 2007. - Vol. 79. - P. 898-906.

12. Мартов, А. Г. Опыт применения дутастерида перед трансуретральной резекцией простаты по поводу аденомы больших размеров / А. Г. Мартов, Д. В. Ергаков // Урология. - 2008. - № 4. - С. 46-50.

13. Ткачук, В.Н. Эффективность нового ингибитора 5-альфа-редуктазы Аводарта у больных аденомой предстательной железы / В. Н. Ткачук // Материалы XI съезда урологов России. - М., 2007. - С. 604-605.

14. Пушкарь, Д. Ю. Опыт применения короткого курса дутастерида у больных с доброкачественной гиперплазией простаты перед выполнением ТУРП / Д. Ю. Пушкарь, К. Б. Колонтарев // Эффективная фармакотерапия. Урология. - 2009. - № 3. - С. 36-39.

15. Лопаткин, Н. А. Доброкачественная гиперплазия предстательной железы / под ред. Н. А. Лопаткина. - М., 1997. - 332 с.

16. Parsons, J. K. Benign prostatichy perplasia and malelow erurinary tractsymptoms: epidemiology and riskfactors / J. K. Parsons // Curr. Bladder Dysfunct. Rep. - 2010. - Vol. 5, № 4. - Р. 212-218.

17. Abrams, P. Sphincterometry in the diagnosis of male bladderout flow obstruction / P. Abrams // J. Urol. - 2006. - Vol. 116. - P. 489-492.


Review

For citations:


Simchenko N.I., Lemtyugov M.B., Bykova O.O. ALTERNATIVE APPROACH IN TREATMENT OF ACUTE URINARY RETENTION IN BENIGN PROSTATIC HYPERPLASIA. Health and Ecology Issues. 2017;(1):54-57. (In Russ.) https://doi.org/10.51523/2708-6011.2017-14-1-11

Views: 309


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2220-0967 (Print)
ISSN 2708-6011 (Online)